Kello M, Goga M, Kotorova K, Sebova D, Frenak R, Tkacikova L
Plants (Basel). 2023; 12(3).
PMID: 36771693
PMC: 9919983.
DOI: 10.3390/plants12030611.
Akasov R, Drozdova M, Zaytseva-Zotova D, Leko M, Chelushkin P, Marc A
Adv Pharm Bull. 2018; 7(4):593-601.
PMID: 29399549
PMC: 5788214.
DOI: 10.15171/apb.2017.071.
Mangal S, Gao W, Li T, Zhou Q
Acta Pharmacol Sin. 2017; 38(6):782-797.
PMID: 28504252
PMC: 5520191.
DOI: 10.1038/aps.2017.34.
He J, Liang X, Luo F, Chen X, Xu X, Wang F
J Cancer. 2016; 7(8):900-9.
PMID: 27313779
PMC: 4910581.
DOI: 10.7150/jca.14506.
Tesson M, Rae C, Nixon C, Babich J, Mairs R
J Pharm Pharmacol. 2016; 68(7):912-21.
PMID: 27139157
PMC: 5298040.
DOI: 10.1111/jphp.12558.
Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.
Au J, Yeung B, Wientjes M, Lu Z, Wientjes M
Adv Drug Deliv Rev. 2015; 97:280-301.
PMID: 26686425
PMC: 4829347.
DOI: 10.1016/j.addr.2015.12.002.
E-cadherin increasing multidrug resistance protein 1 via hypoxia-inducible factor-1α contributes to multicellular resistance in colorectal cancer.
Liang X, Xu X, Wang F, Li N, He J
Tumour Biol. 2015; 37(1):425-35.
PMID: 26219897
DOI: 10.1007/s13277-015-3811-6.
Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy.
Crawford S
Front Pharmacol. 2013; 4:68.
PMID: 23805101
PMC: 3691519.
DOI: 10.3389/fphar.2013.00068.
Evaluation of therapeutics in three-dimensional cell culture systems by MALDI imaging mass spectrometry.
Liu X, Weaver E, Hummon A
Anal Chem. 2013; 85(13):6295-302.
PMID: 23724927
PMC: 4118837.
DOI: 10.1021/ac400519c.
Predictive models of diffusive nanoparticle transport in 3-dimensional tumor cell spheroids.
Gao Y, Li M, Chen B, Shen Z, Guo P, Wientjes M
AAPS J. 2013; 15(3):816-31.
PMID: 23605950
PMC: 3691442.
DOI: 10.1208/s12248-013-9478-2.
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.
Mehta G, Hsiao A, Ingram M, Luker G, Takayama S
J Control Release. 2012; 164(2):192-204.
PMID: 22613880
PMC: 3436947.
DOI: 10.1016/j.jconrel.2012.04.045.
Predicting drug pharmacokinetics and effect in vascularized tumors using computer simulation.
Sinek J, Sanga S, Zheng X, Frieboes H, Ferrari M, Cristini V
J Math Biol. 2008; 58(4-5):485-510.
PMID: 18781304
PMC: 2782117.
DOI: 10.1007/s00285-008-0214-y.
Drug delivery and transport to solid tumors.
Jang S, Wientjes M, Lu D, Au J
Pharm Res. 2003; 20(9):1337-50.
PMID: 14567626
DOI: 10.1023/a:1025785505977.
The expression of P-glycoprotein does influence the distribution of novel fluorescent compounds in solid tumour models.
Martin C, Walker J, Rothnie A, Callaghan R
Br J Cancer. 2003; 89(8):1581-9.
PMID: 14562035
PMC: 2394330.
DOI: 10.1038/sj.bjc.6601300.
Acquired multicellular-mediated resistance to alkylating agents in cancer.
Kobayashi H, Man S, Graham C, Kapitain S, Teicher B, Kerbel R
Proc Natl Acad Sci U S A. 1993; 90(8):3294-8.
PMID: 8475071
PMC: 46286.
DOI: 10.1073/pnas.90.8.3294.
Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging.
Olive P, Banath J, Evans H
Br J Cancer. 1993; 67(3):522-30.
PMID: 8382510
PMC: 1968270.
DOI: 10.1038/bjc.1993.97.
Drug and radiation resistance in spheroids: cell contact and kinetics.
Olive P, Durand R
Cancer Metastasis Rev. 1994; 13(2):121-38.
PMID: 7923546
DOI: 10.1007/BF00689632.
Inhibition of the regulation of intracellular pH: potential of 5-(N,N-hexamethylene) amiloride in tumour-selective therapy.
Luo J, Tannock I
Br J Cancer. 1994; 70(4):617-24.
PMID: 7917906
PMC: 2033413.
DOI: 10.1038/bjc.1994.360.
Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.
Siim B, Atwell G, Wilson W
Br J Cancer. 1994; 70(4):596-603.
PMID: 7917903
PMC: 2033401.
DOI: 10.1038/bjc.1994.357.
The biological activity of cisplatin and dibromodulcitol in combination therapy.
Jeney A, Kovalszky I, Raso E, Durand R, Furesz J, Lapis K
Br J Cancer. 1995; 71(2):317-21.
PMID: 7841047
PMC: 2033585.
DOI: 10.1038/bjc.1995.63.